BALTIMORE, MD—Medical, translational, and research geneticists are invited to register for a complimentary symposium, Exploring Novel Approaches to Therapies for Gaucher’s Disease. Sponsored by Med-IQ, an ACCME-accredited provider of continuing medical education (CME), this independently supported ancillary event will be held during ASHG 2014 in San Diego.
The interactive event will cover key topics in Gaucher’s disease—a rare, genetic lysosomal storage disease that has been treated with enzyme-replacement therapy (ERT) since the treatment was approved in 1991. In recent years, new treatment approaches have been explored, potentially altering long-standing treatment paradigms. In addition to reviewing these emerging strategies, symposium faculty Drs. Pramod K. Mistry and T. Andrew Burrow will discuss the application of genetics to therapeutic approaches as well as benefits and limitations of available medications.
“Through an engaging didactic presentation, this CME-certified session will discuss the rationale of targeting the glycosphingolipid biosynthetic and degradative pathways for the management of Gaucher’s disease,” said Pramod K. Mistry, MD, Yale University School of Medicine. “In addition, Dr. Burrow and I will present contemporary evidence that supports emerging therapeutic agents, including alternatives to ERT, for treating patients with Gaucher’s disease.”
The CME symposium will be held in San Diego during the 64th Annual Meeting of the American Society of Human Genetics (ASHG 2014) on Monday, October 20, 2014, at 6:30 AM in Room 25ABC, Upper Level of the San Diego Convention Center. Interested participants can pre-register by completing this brief online form, calling (toll-free) 866 858 7434, or e-mailing email@example.com.
Pramod K. Mistry, MD, PhD
Professor of Medicine, Pediatrics, and Cellular & Molecular Physiology
Director, Metabolic Liver and Lysosomal Disease Program
Yale University School of Medicine
Department of Internal Medicine (Digestive Diseases)
Yale New Haven Hospital
New Haven, CT
T. Andrew Burrow, MD
Assistant Professor of Clinical Pediatrics
University of Cincinnati College of Medicine
Department of Pediatrics
Division of Human Genetics
Cincinnati Children’s Hospital Medical Center
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
Senior Audience Development Manager
866 858 7434
Inspiring Medical Education.